Vontobel Holding Ltd. purchased a new stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 15,842 shares of the electronics maker's stock, valued at approximately $1,237,000.
Other institutional investors have also modified their holdings of the company. CWM LLC lifted its stake in Dolby Laboratories by 27.9% in the third quarter. CWM LLC now owns 3,978 shares of the electronics maker's stock valued at $304,000 after buying an additional 868 shares during the last quarter. Creative Planning increased its stake in shares of Dolby Laboratories by 7.5% in the third quarter. Creative Planning now owns 4,094 shares of the electronics maker's stock valued at $313,000 after purchasing an additional 286 shares during the period. Net Worth Advisory Group bought a new stake in shares of Dolby Laboratories during the third quarter valued at approximately $260,000. Blue Trust Inc. grew its holdings in Dolby Laboratories by 234.3% in the 3rd quarter. Blue Trust Inc. now owns 1,384 shares of the electronics maker's stock worth $110,000 after buying an additional 970 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new stake in Dolby Laboratories during the 3rd quarter valued at $3,895,000. Institutional investors own 58.56% of the company's stock.
Dolby Laboratories Stock Down 1.1 %
Dolby Laboratories stock traded down $0.90 during midday trading on Friday, hitting $81.42. The company's stock had a trading volume of 646,093 shares, compared to its average volume of 481,564. Dolby Laboratories, Inc. has a 12 month low of $66.35 and a 12 month high of $89.66. The stock's 50-day moving average price is $80.61 and its 200-day moving average price is $76.31. The company has a market capitalization of $7.77 billion, a PE ratio of 29.94 and a beta of 0.98.
Dolby Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories's payout ratio is 48.53%.
Wall Street Analyst Weigh In
DLB has been the subject of several recent analyst reports. Rosenblatt Securities reissued a "buy" rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, January 30th. Barrington Research reiterated an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, February 13th. Finally, StockNews.com lowered Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st.
View Our Latest Research Report on Dolby Laboratories
Insider Activity
In other Dolby Laboratories news, SVP John D. Couling sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $80.50, for a total transaction of $563,500.00. Following the transaction, the senior vice president now directly owns 106,806 shares in the company, valued at approximately $8,597,883. The trade was a 6.15 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Yeaman sold 50,000 shares of the firm's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $80.54, for a total value of $4,027,000.00. Following the completion of the sale, the chief executive officer now directly owns 83,721 shares of the company's stock, valued at approximately $6,742,889.34. This trade represents a 37.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 144,959 shares of company stock valued at $11,897,065 over the last three months. Insiders own 38.39% of the company's stock.
Dolby Laboratories Company Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Recommended Stories

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.